373 related articles for article (PubMed ID: 16750852)
61. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
[TBL] [Abstract][Full Text] [Related]
62. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts.
van Lochem EG; van der Velden VH; Wind HK; te Marvelde JG; Westerdaal NA; van Dongen JJ
Cytometry B Clin Cytom; 2004 Jul; 60(1):1-13. PubMed ID: 15221864
[TBL] [Abstract][Full Text] [Related]
63. [Preliminary study of diagnosis of patients with myelodysplastic syndromes by routine laboratory parameters].
Li L; Nie L; Yu MH; Zheng YZ; Zhang Y; Xu ZF; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):623-8. PubMed ID: 19175993
[TBL] [Abstract][Full Text] [Related]
64. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
65. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of a Bone Marrow Dysmyelopoiesis Immunophenotypic Index for the Diagnosis and Prognosis of Myelodysplastic Syndromes.
Verigou E; Lampropoulou P; Smyrni N; Kolliopoulou G; Sakellaropoulos G; Starakis I; Zikos P; Solomou E; Symeonidis A; Karakantza M
Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):148-61. PubMed ID: 26126819
[TBL] [Abstract][Full Text] [Related]
67. Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias.
Cutler JA; Wells DA; van de Loosdrecht AA; de Baca ME; Kalnoski MH; Zehentner BK; Eidenschink L; Ghirardelli KM; Biggerstaff JS; Loken MR
Cytometry B Clin Cytom; 2011 May; 80(3):150-7. PubMed ID: 21520402
[TBL] [Abstract][Full Text] [Related]
68. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia.
Kussick SJ; Fromm JR; Rossini A; Li Y; Chang A; Norwood TH; Wood BL
Am J Clin Pathol; 2005 Aug; 124(2):170-81. PubMed ID: 16040286
[TBL] [Abstract][Full Text] [Related]
69. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
70. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
[TBL] [Abstract][Full Text] [Related]
71. Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
Riccardi A; Montecucco CM; Danova M; Ucci G; Mazzini G; Giordano PA; Pasquali F
Basic Appl Histochem; 1986; 30(2):181-92. PubMed ID: 2427061
[TBL] [Abstract][Full Text] [Related]
72. Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities.
López-Holgado N; Arroyo JL; Pata C; Villarón E; Sánchez Guijo F; Martín A; Hernández Rivas JM; Orfao A; San Miguel JF; Del Cañizo Fernández-Roldán MC
Leuk Res; 2004 Nov; 28(11):1181-7. PubMed ID: 15380343
[TBL] [Abstract][Full Text] [Related]
73. Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow.
Olteanu H; Karandikar NJ; McKenna RW; Xu Y
Am J Clin Pathol; 2006 Nov; 126(5):781-8. PubMed ID: 17050075
[TBL] [Abstract][Full Text] [Related]
74. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
75. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
Rajab A; Porwit A
Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
[TBL] [Abstract][Full Text] [Related]
76. Identification of unsuspected PNH-type cells in flow cytometric immunophenotypic analysis of peripheral blood and bone marrow.
Thomason RW; Papiez J; Lee RV; Szczarkowski W
Am J Clin Pathol; 2004 Jul; 122(1):128-34. PubMed ID: 15272541
[TBL] [Abstract][Full Text] [Related]
77. High incidence of apoptosis in peripheral blood of myelodysplastic syndrome patients determined by Papanicolaou-stained preparations.
Emura I
Lab Hematol; 2003; 9(1):42-6. PubMed ID: 12661827
[TBL] [Abstract][Full Text] [Related]
78. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
Wimazal F; Fonatsch C; Thalhammer R; Schwarzinger I; Müllauer L; Sperr WR; Bennett JM; Valent P
Leuk Res; 2007 Nov; 31(11):1461-8. PubMed ID: 17507091
[TBL] [Abstract][Full Text] [Related]
79. [Study of Th cell subsets in bone marrow of myelodysplastic syndromes patients].
Wang XL; Shao ZH; Yao C; He GS; Liu H; Shi J; Bai J; Cao YR; Tu MF; Wang HQ; Xing LM; Sun J; Jia HR; Yang CL
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):743-5. PubMed ID: 16620580
[TBL] [Abstract][Full Text] [Related]
80. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
